Organization: Fonds de la recherche en santé du Québec

Pfizer boosts investment in Quebec-based research

Pfizer Canada has increased its investments in R&D projects managed by the Fonds de la recherche en santé du Québec (FRSQ) to $22 million. The latest investment of $5 million in the Pfizer-FRSQ-MSSS Chronic Disease Fund has produced an initial series of five projects valued at $3.5 million. The projects will be carried out by…

Quebec research program on cancer risk receives $30M

The Cancer Research Society is providing $15 million towards an environmental cancer research and prevention program in Quebec. The government — through the Ministry of Economic Development, Innovation and Export — will match the CRS’s contribution, creating a fund of $30 million over five years. The program will be administered by the Fonds de la…

Quebec Consortium for Drug Discovery launched

A new Quebec Consortium for Drug Discovery has been announced at Bio 2008 in San Diego. The public private partnership has received $7 million in commitments in its first year of operation and will be headed by Max Fehlmann. Pfizer Canada, AstraZeneca Canada and Merck Frosst Canada have each committed $1 million in the first…

Pfizer invests $10 million in fund for promising research

Pfizer Canada is investing $10 million over five years to create the Pfizer-FRSQ Innovation Fund to support research that has a high potential for tech transfer and commercialization in the short and medium terms. The fund will be managed by the Fonds de la recherche en santé du Québec (FRSQ) and is open to the…